Views & Analysis 2021 market access prospects for France In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring
News AZ COVID jab efficacy debate is hindering EU’s vaccine drive The spat between the EU and AstraZeneca over access to the company’s COVID-19 shot led to scathing remarks about its efficacy that now threaten to undermine the EU’s vaccination targets.
Views & Analysis How does HTA for orphan drugs differ across Europe? New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines across Europe.
News Sanofi pledges €10m to Notre Dame, but faces backlash Sanofi has said that it will donate 10 million Euros to the rebuilding of Notre Dame cathedral in Paris, prompting a mixed response from the public.
Views & Analysis Macron’s France: advancing towards a European vision for hea... What will Macron's government mean for healthcare in his country and Europe?
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
